Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors

Completed · Not applicable

Conditions studied: Breast Cancer

In brief

This study aims to establish the feasibility of using a monthly bubble package to improve compliance rates among women prescribed adjuvant endocrine therapy.

Key facts

Study ID

NCT01694225

Run by

University of Louisville

People needed

87

Starts

2012-07-01

Expected to finish

2018-01-28

Last updated by the study team

2018-01-31

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age or older
• Estrogen receptor positive (> 1% estrogen expression) by immunohistochemistry
• Invasive breast cancer (stage I, II, III) or DCIS considered for adjuvant endocrine therapy

You may not qualify if…

• Patients with metastatic disease (stage IV)
• Patients less than 18 years of age
• Prisoners
• Patients are unable to fill prescriptions at the BCC pharmacy due to insurance limitations or personal preference

Where it is running

• James Graham Brown Cancer Center-University of Louisville — Louisville, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.